September 17, 2012
|
Program Result Report
From late 2008 through 2011, the team from the Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH) built a biorepository to support studies of genetic and environmental contributors to many common diseases.
April 17, 2006
|
Program Result Report
Since 1991, RWJF has funded 32 grants and contracts totaling about $7 million for projects related to genetics, genetic technologies and genetic services.
July 1, 2004
|
Program Result Report
The American Nurses Foundation established the National Coalition for Health Professional Education in Genetics, an interdisciplinary group that brings together organizations to promote health professional education in the area of human genetics.
May 1, 2001
|
Program Result Report
The State of Arizona Department of Health Services held a conference on the future impact of advances in genetics. "Genetics in the 21st Century: Crisis and Opportunity" took place May 12-14, 1999, in Mesa, Ariz.
May 1, 1997
|
Program Result Report
The Banbury Center at the Cold Spring Harbor Laboratory convened two meetings to explore the implications for health care of advances in human genetics:
December 1, 2005
|
Program Result Report
The March of Dimes Birth Defects Foundation designed, launched and evaluated Genetics & Your Practice Online, an information and continuing education program to help health professionals integrate genetics into their practices.
December 1, 2004
|
Program Result Report
Fred Friendly Seminars, in association with Thirteen/WNET, produced a three-part series called Our Genes/Our Choices, which the Public Broadcasting Service (PBS) premiered nationally in January 2003 to some 2.3 million viewers.
March 1, 2008
|
Program Result Report
The National Coalition for Health Professional Education in Genetics produced and disseminated a 90-minute television program to educate health care professionals about the role of race and genetics in health care.
July 31, 2008
|
Program Result Report
Pharmacogenomics is the study of how inherited variations in genes dictate a person's reaction to a drug. Louis F. Rossiter, PhD, and other researchers examined how pharmacogenomics fits within the current health care market.